Search for: "U.S. Compounding Inc."
Results 1 - 20
of 872
Sorted by Relevance
|
Sort by Date
19 Mar 2019, 9:55 pm
Creative Compounds, LLC, the Federal Circuit reversed and remanded a decision by the U.S. [read post]
26 Sep 2020, 9:15 am
Teleflex Inc., 127 S. [read post]
24 Oct 2011, 4:09 pm
As to related litigation, Compound Photonics states that it filed a complaint against Sony Corporation and Sony Electronics Inc. in the U.S. [read post]
8 Nov 2023, 4:15 am
On August 22, 2023, the U.S. [read post]
8 Nov 2023, 4:15 am
On August 22, 2023, the U.S. [read post]
14 Feb 2019, 9:50 pm
Research Corporation Technologies, Inc. [read post]
19 Aug 2014, 6:30 am
The U.S. [read post]
11 Aug 2013, 5:30 pm
Fax: 1-800-FDA-0178 This recall is being conducted with the knowledge of the U.S. [read post]
16 Feb 2007, 7:53 am
Singer In a February 14, 2006 press release, Idera Pharmaceuticals, Inc. announced that U.S. [read post]
7 Apr 2013, 4:21 pm
Pallimed Solutions, Inc. of Woburn, MA, doing business as Pallimed Pharmacy, is voluntarily recalling all sterile compound products dispensed since January 1, 2013 to the user level.The recall resulted from a recent inspection conducted by the U.S. [read post]
1 Oct 2019, 9:59 pm
Arkema Inc., the Federal Circuit vacated a combined Final Written Decision by the U.S. [read post]
2 Mar 2015, 9:59 pm
The '374 patent, which is directed to the compound cobicistat, is owned by Gilead Sciences, Inc. [read post]
13 Jun 2022, 1:11 pm
The U.S. [read post]
14 Jan 2016, 7:25 pm
A recent case shows what happens when retail pharmacies engage in compounding with regulation by the state and what happens when the U.S. [read post]
26 Apr 2007, 9:31 pm
Singer -- In an April 26, 2007 press release SciClone Pharmaceuticals Inc. announced that it acquired exclusive rights in the U.S. and Canada to develop and commercialize a compound in the clinical stage for treatment of pancreatic cancer. [read post]
16 Jun 2023, 12:16 pm
Smart Pharmacy, Inc., et al., No. 16-cv-387 (M.D. [read post]
20 Apr 2010, 9:30 am
The FDA is concerned that the company's continued compounding practices pose a significant public health risk, as evidenced by the deaths of 21 polo ponies April 19, 2009, before a match in the U.S. [read post]
27 Aug 2012, 9:31 am
U.S. [read post]
27 Aug 2012, 9:31 am
U.S. [read post]
19 Aug 2008, 3:37 am
By Jason Derry -- Tobira Therapeutics Inc. has announced that the U.S. [read post]
